⚠ Canada's CAD 32.5 Billion SettlementModerate threat

Philip Morris International (PM) — threat to the moat

Canada's CAD 32.5 billion settlement has cost PMI $2.8 billion of impairments, and the same kind of claim is still open in Brazil, South Korea and Nigeria.

The clearest example of what the cigarette's past can cost is Canada. PMI's Canadian subsidiary RBH filed for creditor protection under Canada's CCAA on 22 March 2019 and was deconsolidated, its investment carried at a fair value of $3,280 million1. The plan that ended the proceedings provided for an aggregate global settlement of CAD 32.5 billion, about $23.7 billion at the end of 2025, payable by RBH, Imperial Tobacco Canada and JTI-Macdonald2. The court approved it on 6 March 2025 and it took effect on 29 August 20253.

The Canadian settlement22 Mar 2019RBH filesunder CCAA2024$2,316Mimpairment6 Mar 2025CAD 32.5bnplan approved29 Aug 2025plan effectiveQ2 2026$511Mimpairment,$51M leftPMI Form 10-K FY2025; Q2 2026 results release
A subsidiary written down to $51 million.

PMI has written the investment almost to nothing. It recorded an impairment of $2,316 million in 20244, received a CAD 750 million dividend from RBH on 24 September 20255, and took a further non-cash impairment of $511 million in the second quarter of 2026, leaving a carrying value of $51 million67. The two impairments total $2,827 million8.

The charges have distorted PMI's reported earnings. The 2024 impairment cut diluted earnings per share by $1.499, which is why reported earnings fell to $4.52 that year; the 2026 charge cost about 33 cents a share10.

The larger lesson is precedent. The settlement was structured through a subsidiary under court protection, which kept the liability away from the parent but cost it almost the entire value of the investment. Health-care cost recovery actions in Brazil, South Korea and Nigeria remain open11.

Canada is now mostly behind PMI. The carrying value of the investment will show it first only until it reaches zero; the real test is whether another country applies a Canadian-style framework to PMI's operations there.

The number that tests this threat
Reported
Carrying value of the RBH investment
$51M (30 June 2026), from $3,280M at deconsolidation

What is left of the Canadian subsidiary; the next test is whether another country copies the settlement.

Source: PMI Q2 2026 results release ↗
References
  1. ReportedPMI's Canadian subsidiary RBH filed for creditor protection under Canada's CCAA on 22 March 2019 and was deconsolidated, its investment carried at a fair value of $3,280 million.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
  2. ReportedThe plan that ended the proceedings provided for an aggregate global settlement of CAD 32.5 billion, about $23.7 billion at the end of 2025, payable by RBH, Imperial Tobacco Canada and JTI-Macdonald.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
  3. ReportedThe court approved it on 6 March 2025 and it took effect on 29 August 2025.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
  4. ReportedIt recorded an impairment of $2,316 million in 2024, received a CAD 750 million dividend from RBH on 24 September 2025, and took a further non-cash impairment of $511 million in the second quarter of 2026, leaving a carrying value of $51 million.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  5. ReportedIt recorded an impairment of $2,316 million in 2024, received a CAD 750 million dividend from RBH on 24 September 2025, and took a further non-cash impairment of $511 million in the second quarter of 2026, leaving a carrying value of $51 million.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
  6. ReportedIt recorded an impairment of $2,316 million in 2024, received a CAD 750 million dividend from RBH on 24 September 2025, and took a further non-cash impairment of $511 million in the second quarter of 2026, leaving a carrying value of $51 million.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - results, margins, operating companies income, cash and 2026 guidance. — Q2 2026 · publ. 22 July 2026 · source ↗
  7. ReportedIt recorded an impairment of $2,316 million in 2024, received a CAD 750 million dividend from RBH on 24 September 2025, and took a further non-cash impairment of $511 million in the second quarter of 2026, leaving a carrying value of $51 million.
    Philip Morris International dbAccess conference release, 2 June 2026 - the RBH impairment and ZYN ULTRA. — June 2026 · publ. 2 June 2026 · source ↗
  8. Moat Explorer calcThe two impairments total $2,827 million.
    Moat Explorer calculation from Philip Morris International's reported figures ($ millions unless stated). Excise and revenue 2025: 53,211 / 40,648 = 1.31 dollars of excise per dollar of net revenue; gross of excise 53,211 + 40,648 = 93,859, excise share 53,211 / 93,859 = 56.7%; excise growth 2023-2025 53,211 / 49,404 - 1 = 7.7% against net revenue growth 40,648 / 35,174 - 1 = 15.6%. Product mix 2025: smoke-free 16,854 / 40,648 = 41.5%; combustible 23,794 / 40,648 = 58.5%; smoke-free 2023 12,840 / 35,174 = 36.5%, 2024 14,660 / 37,878 = 38.7%; smoke-free growth 2023-2025 16,854 / 12,840 - 1 = 31.3%; smoke-free revenue 2016 733 to 2025 16,854 = 23 times. Segments 2025: International Smoke-Free 13,996 / 40,648 = 34.4%; International Combustibles 23,436 / 40,648 = 57.7%; U.S. 3,216 / 40,648 = 7.9%; recast gross profit shares 9,576 / 27,304 = 35.1%, 15,523 / 27,304 = 56.9%, 2,206 / 27,304 = 8.1%. Growth 2025: ISF 13,996 / 12,126 - 1 = 15.4%; IC 23,436 / 22,807 - 1 = 2.8%; U.S. 3,216 / 2,944 - 1 = 9.2%. Growth 2024: ISF 12,126 / 11,102 - 1 = 9.2%; IC 22,807 / 21,903 - 1 = 4.1%; U.S. 2,944 / 2,169 - 1 = 35.7%. IC gross profit 15,523 / 13,972 - 1 = 11.1% against IC revenue 23,436 / 21,903 - 1 = 7.0% (2023-2025). Recast reported gross margins 2023: ISF 7,021 / 11,102 = 63.2%, IC 13,972 / 21,903 = 63.8%; 2024: ISF 7,831 / 12,126 = 64.6%, IC 14,687 / 22,807 = 64.4%. Segment sum 2024 12,126 + 22,807 + 2,944 = 37,877 against 37,878 reported. IC shares of net revenues 21,903 / 35,174 = 62.3% (2023), 22,807 / 37,878 = 60.2% (2024). U.S. revenue 3,216 / 2,169 - 1 = 48.3% (2023-2025). Q2 2026 shares: ISF 3,877 / 11,192 = 34.6%, IC 6,459 / 11,192 = 57.7%, U.S. 856 / 11,192 = 7.6%. U.S. gross margin Q2 2026 555 / 856 = 64.8% against 611 / 862 = 70.9%. Swedish Match: 14,460 + 1,495 + 883 = 16,838 total cash paid; U.S. adjusted operating companies income 1,124 / 16,838 = 6.7% pre-tax; reported U.S. OCI 322 / 3,216 = 10.0% of U.S. revenue; adjusted 1,124 / 3,216 = 35.0%. Goodwill and other intangibles 17,264 + 10,884 = 28,148, 28,148 / 69,185 = 40.7% of total assets. Volumes: cigarettes 607,367 / 616,827 - 1 = -1.5% (2025), 607,367 / 612,949 - 1 = -0.9% (2023-2025); heated tobacco units 155,133 / 139,743 - 1 = 11.0% (2025), 139,743 / 125,263 - 1 = 11.6% (2024); HTUs 155,133 / (607,367 + 155,133) = 20.3% of cigarette plus HTU shipments. U.S. ZYN cans 793.7 / 384.8 = 2.06 times (2023-2025), 793.7 / 580.5 - 1 = 36.7% (2025); international nicotine pouches 879.6 - 793.7 = 85.9 million cans (2025), 644.0 - 580.5 = 63.5 (2024); snus 227.9 / 240.4 - 1 = -5.2% (2023-2025); e-vapor 3,330 / 1,651 = 2.0 times. U.S. segment: cigars 358 / 410 - 1 = -12.7%, 358 / 431 - 1 = -16.9% (2023-2025); wellness 238 / 333 - 1 = -28.5%. Cash and dividends: free cash flow 12,233 - 1,569 = 10,664 (2025), 12,217 - 1,444 = 10,773 (2024), 9,204 - 1,321 = 7,883 (2023); dividends paid / free cash flow 8,624 / 10,664 = 80.9% (2025), 8,197 / 10,773 = 76.1% (2024), 7,964 / 7,883 = 101.0% (2023). Payout of declared dividends per share over diluted EPS: 5.64 / 7.26 = 77.7% (2025), 5.30 / 4.52 = 117.3% (2024), 5.14 / 5.02 = 102.4% (2023); over adjusted EPS 5.64 / 7.54 = 74.8%. Annualised dividend 1.60 x 4 = 6.40; 6.40 / 5.64 = 1.13; dividend 5.64 / 1.54 = 3.7 times since 2008; yield 6.40 / 190.48 = 3.4%. R&D 756 / 40,648 = 1.9% of revenue; capex 1,569 / 40,648 = 3.9%. Customers: two customers 12% + 10% = 22% of 2025 net revenues; related-party revenue 4,582 / 40,648 = 11.3%; Megapolis 2,805 / 40,648 = 6.9%; Megapolis growth 2,805 / 2,393 - 1 = 17.2%. Japan 4.2 / 40.6 = 10.3% of net revenues. Canada: RBH carrying value 3,280 fair value at deconsolidation to 51 at 30 June 2026; impairments 2,316 + 511 = 2,827. Valuation: trailing twelve months to June 2026 revenue 40,648 + 21,338 - 19,441 = 42,545; net earnings 11,348 + 5,255 - 5,729 = 10,874; P/E 296.88 / 10.874 = 27.3; P/S 296.88 / 42.545 = 6.98; 2018 P/E 103.78 / 7.911 = 13.1; 2025 P/E 249.68 / 11.348 = 22.0; free cash flow yield 10,664 / 296,880 = 3.6%. Other PMI cigarette brands: 25.4 - 9.8 = 15.6% (2023), 25.3 - 10.7 = 14.6% (2025), a loss of 1.0 point against Marlboro's gain of 0.9. Excise Q2 2026 14,973 / 13,272 - 1 = 12.8% against net revenues 11,192 / 10,140 - 1 = 10.4%. U.S. smoke-free H1 1,584 - 1,311 = 273 decline. ISF H1 2026 gross margin 5,400 / 7,713 = 70.0%. Gross margin 2025 27,282 / 40,648 = 67.1%. ROIC average 2015-2025 (45.6 + 50.2 + 43.4 + 50.7 + 48.7 + 52.1 + 57.2 + 40.6 + 26.8 + 28.6 + 32.5) / 11 = 43.3%. Employees 84,900 - 82,700 = 2,200 (2023-2025); net revenues 40,648 - 35,174 = 5,474, about 5.5 billion. Snus 240.4 - 227.9 = 12.5 million cans. Europe smoke-free 8,127 / 16,854 = 48.2%, about half. Cigarette decline 2% to 3% of 607,367 = 12,147 to 18,221 million units. Operating cash flow over R&D 12,233 / 756 = 16.2 times. Blocked markets 440 / 2,587 = 17%, about a sixth. Market cap against peers 296.88 / 119.41 = 2.5 times British American Tobacco; 296.88 / 114.91 = 2.6 times Altria. Net debt to adjusted EBITDA 43,963 / 17,375 = 2.53. Interest 966 / 14,892 = 6.5% of operating income. Guidance midpoints: (8.35 + 8.50) / 2 = 8.43, reported (7.28 + 7.43) / 2 = 7.36, gap 8.43 - 7.36 = 1.07; earlier adjusted midpoints (8.38 + 8.53) / 2 = 8.46, (8.31 + 8.46) / 2 = 8.39, (8.26 + 8.41) / 2 = 8.34; 8.43 / 7.54 - 1 = 11.8% - growth rates, volumes, margins and excise. — 2015-2026 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in PMI's Forms 10-K and 10-Q, the recast segment schedules, results releases and market data; operands shown in the source line.
  9. ReportedThe 2024 impairment cut diluted earnings per share by $1.49, which is why reported earnings fell to $4.52 that year; the 2026 charge cost about 33 cents a share.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  10. ReportedThe 2024 impairment cut diluted earnings per share by $1.49, which is why reported earnings fell to $4.52 that year; the 2026 charge cost about 33 cents a share.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - results, margins, operating companies income, cash and 2026 guidance. — Q2 2026 · publ. 22 July 2026 · source ↗
  11. ReportedHealth-care cost recovery actions in Brazil, South Korea and Nigeria remain open.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
Sources
Generated September 26, 2026